Funder
Chiesi Farmaceutici
Chiesi USA Inc
Duke Clinical Research Institute
Reference16 articles.
1. Effect of platelet inhibition with cangrelor during PCI on ischemic events;Bhatt;N Engl J Med,2013
2. Antiplatelet therapy after percutaneous coronary intervention;Angiolillo;EuroIntervention,2022
3. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Lawton;Circulation,2022
4. Antithrombotic therapy for patients with STEMI undergoing primary PCI;Franchi;Nat Rev Cardiol,2017
5. Timing, selection, modulation, and duration of P2Y12 inhibitors for patients with acute coronary syndromes undergoing PCI;Capodanno;J Am Coll Cardiol Interv,2023